Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Fradet

Showing results (51-60 of 240) with videos related to

Pageof 24
Sort By:
Cancer|June 11, 2008
Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancer: how much is enough?Marc Decobert, Hélène LaRue, François Harel, et al.
Trends in Molecular Medicine|May 15, 2025
New insights into gut microbiota-prostate cancer crosstalkJalal Laaraj, Gabriel Lachance, Alain Bergeron, et al.
Scientific Reports|September 29, 2016
Bioluminescence Microscopy as a Method to Measure Single Cell Androgen Receptor Activity Heterogeneous Responses to AntiandrogensPallavi Jain, Bertrand Neveu, Lauriane Velot, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2009
Gleason grading controversies: what the chemoprevention trials have taught usLaurence Klotz, Darrel Drachenberg, Yves Fradet, et al.
World Journal of Urology|January 25, 2012
Long-term PSA-free survival and castration-free survival with delayed antiandrogen therapy in patients with one versus two or more positive nodes at prostatectomyMichele Lodde, Louis Lacombe, Angelo Naselli, et al.
Cancer Immunology, Immunotherapy : CII|January 14, 2016
Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancerCherifa Ayari, Marjorie Besançon, Alain Bergeron, et al.
Clinical Genitourinary Cancer|October 10, 2019
Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?Catherine McMartin, Louis Lacombe, Vincent Fradet, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mLStéphane Bolduc, Louis Lacombe, Alain Naud, et al.
Cancer Research|March 18, 2004
Accelerated induction of bladder cancer in patched heterozygous mutant miceSahar Hamed, Hélène LaRue, Hélène Hovington, et al.
Urologic Oncology|October 22, 2022
Analysis of sex-based differences to Bacillus Calmette-Guérin for non-muscle invasive bladder cancerJonathan Fadel, David Simonyan, Vincent Fradet, et al.
Pageof 24

Showing results (51-60 of 240) with videos related to

Sort By:
Pageof 24
Cancer|June 11, 2008
Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancer: how much is enough?Marc Decobert, Hélène LaRue, François Harel, et al.
Trends in Molecular Medicine|May 15, 2025
New insights into gut microbiota-prostate cancer crosstalkJalal Laaraj, Gabriel Lachance, Alain Bergeron, et al.
Scientific Reports|September 29, 2016
Bioluminescence Microscopy as a Method to Measure Single Cell Androgen Receptor Activity Heterogeneous Responses to AntiandrogensPallavi Jain, Bertrand Neveu, Lauriane Velot, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2009
Gleason grading controversies: what the chemoprevention trials have taught usLaurence Klotz, Darrel Drachenberg, Yves Fradet, et al.
World Journal of Urology|January 25, 2012
Long-term PSA-free survival and castration-free survival with delayed antiandrogen therapy in patients with one versus two or more positive nodes at prostatectomyMichele Lodde, Louis Lacombe, Angelo Naselli, et al.
Cancer Immunology, Immunotherapy : CII|January 14, 2016
Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancerCherifa Ayari, Marjorie Besançon, Alain Bergeron, et al.
Clinical Genitourinary Cancer|October 10, 2019
Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?Catherine McMartin, Louis Lacombe, Vincent Fradet, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mLStéphane Bolduc, Louis Lacombe, Alain Naud, et al.
Cancer Research|March 18, 2004
Accelerated induction of bladder cancer in patched heterozygous mutant miceSahar Hamed, Hélène LaRue, Hélène Hovington, et al.
Urologic Oncology|October 22, 2022
Analysis of sex-based differences to Bacillus Calmette-Guérin for non-muscle invasive bladder cancerJonathan Fadel, David Simonyan, Vincent Fradet, et al.
Pageof 24